Form 4 for PCVX Vaxcyte, Inc.
Accepted 2021-08-20 00:00:00 ET · period of report 2021-08-19 · accession 0001209191-21-052762 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-20 | 2021-08-19 | PCVX | PICKERING GRANT | CEO, Dir | S - Sale+OE | $22.40 | -1,331 | 580.3K | -0.2% | -$29.8K |
| D | 2021-08-20 | 2021-08-19 | PCVX | PICKERING GRANT | CEO, Dir | M - OptEx | $1.79 | +1,331 | 581.6K | +0.2% | +$2,382 |
| D | 2021-08-20 | 2021-08-19 | PCVX | PICKERING GRANT | CEO, Dir | M - OptEx | $0.00 | -1,331 | 387.5K | -0.3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-19 | S | D | 1,331 | $22.40 | 580,254 | D | — | — | (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $22.135 to $22.62. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2021-08-19 | M | A | 1,331 | $1.79 | 581,585 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2021-08-19 | M | D | 1,331 | $0.00 | 387,484 | D | $1.79 · — to 2027-05-17 | 1,331 Common Stock | (F3) The shares subject to the option are fully vested and exercisable. |